Das, A. http://orcid.org/0000-0002-0086-4760
Alshareef, M.
Martinez Santos, J. L.
Porto, G. B. F.
McDonald, D. G.
Infinger, L. K. http://orcid.org/0000-0003-0072-3500
Vandergrift, W. A. III
Lindhorst, S. M. http://orcid.org/0000-0002-1585-4450
Varma, A. K. http://orcid.org/0000-0001-5481-004X
Patel, S. J. http://orcid.org/0000-0002-3788-6314
Cachia, D. http://orcid.org/0000-0002-5860-8452
Funding for this research was provided by:
American Cancer Society Institutional Research Grant awarded to the Hollings Cancer Center, Medical University of South Carolina
Article History
Received: 24 January 2020
Accepted: 16 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: Pfizer Inc. supplied palbociclib for this study. The results of this research and any intellectual property arising from this research are subject to existing rights and obligations to a third party, Pfizer Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Subjects gave their written, informed consent to participate.